Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Finasteride improves heart function and balance in aging and obese male rats by reducing oxidative stress.

Minoxidil controls blood pressure but may cause kidney damage and needs diuretics to prevent swelling.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Drugs like PDEI may help hair disorders like AGA.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Minoxidil helps heart function but doesn't improve exercise ability and may cause complications.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.